Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1994-5-13
pubmed:abstractText
The biochemical basis for the acquired or natural resistance of various gram-positive organisms to glycopeptides was studied by high-pressure liquid chromatographic analysis of their peptidoglycan UDP-MurNAc-peptide precursors. In all cases, resistance was correlated with partial or complete replacement of the C-terminal D-Ala-D-Ala-containing UDP-MurNAc-pentapeptide by a new precursor with a modified C terminus. Nuclear magnetic resonance analysis by sequential assignment showed that the new precursor encountered in Enterococcus faecium D366, a strain belonging to the VANB class, which expresses low-level resistance to vancomycin, was UDP-MurNAc-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-lactate, identical to that previously found in the VANA class, which expresses high-level resistance to vancomycin. High-pressure liquid chromatographic analyses, composition determinations, and digestion by R39 D,D-carboxypeptidase demonstrated the exclusive presence of the new precursor in Lactobacillus casei and Pediococcus pentosaceus, which are naturally highly resistant to glycopeptides. The low-level natural resistance of Enterococcus gallinarum to vancomycin was found to be associated with the synthesis of a new precursor identified as a UDP-MurNAc-pentapeptide containing a C-terminal D-serine. The distinction between low and high levels of resistance to glycopeptides appeared also to depend on the presence or absence of a substantial residual pool of a D-Ala-D-Ala-containing UDP-MurNAc-pentapeptide.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1459398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1490109, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1510433, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1510445, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1521770, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1522072, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1551598, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1556077, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1908809, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1931965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-1998664, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2069388, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2118867, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2344161, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2400398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2497704, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2532132, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2723455, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2817848, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-2968517, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-4200845, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-4568761, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-5012980, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-5124386, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-6125497, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-6286632, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-7283154, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-8215264, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-8215270, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-8282706, http://linkedlifedata.com/resource/pubmed/commentcorrection/8157610-8440477
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
176
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2398-405
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum.
pubmed:affiliation
Laboratoire de RMN, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't